AU1686302A - Streptococcus pyogenes antigens and corresponding dna fragments - Google Patents

Streptococcus pyogenes antigens and corresponding dna fragments

Info

Publication number
AU1686302A
AU1686302A AU1686302A AU1686302A AU1686302A AU 1686302 A AU1686302 A AU 1686302A AU 1686302 A AU1686302 A AU 1686302A AU 1686302 A AU1686302 A AU 1686302A AU 1686302 A AU1686302 A AU 1686302A
Authority
AU
Australia
Prior art keywords
streptococcus pyogenes
dna fragments
corresponding dna
antigens
pyogenes antigens
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU1686302A
Other languages
English (en)
Inventor
Denis Martin
Bernardr Brodeur
Josee Hamel
Stephane Rioux
Patrick Rheault
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shire Canada Inc
Original Assignee
Shire BioChem Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shire BioChem Inc filed Critical Shire BioChem Inc
Publication of AU1686302A publication Critical patent/AU1686302A/xx
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0208—Specific bacteria not otherwise provided for
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56944—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/315—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Streptococcus (G), e.g. Enterococci
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Toxicology (AREA)
  • Communicable Diseases (AREA)
AU1686302A 2000-12-21 2001-12-21 Streptococcus pyogenes antigens and corresponding dna fragments Pending AU1686302A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25694000P 2000-12-21 2000-12-21
PCT/CA2001/001853 WO2002050107A2 (en) 2000-12-21 2001-12-21 Streptococcus pyogenes antigens and corresponding dna fragments

Publications (1)

Publication Number Publication Date
AU1686302A true AU1686302A (en) 2002-07-01

Family

ID=22974225

Family Applications (2)

Application Number Title Priority Date Filing Date
AU1686302A Pending AU1686302A (en) 2000-12-21 2001-12-21 Streptococcus pyogenes antigens and corresponding dna fragments
AU2002216863A Ceased AU2002216863B8 (en) 2000-12-21 2001-12-21 Streptococcus pyogenes antigens and corresponding DNA fragments

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2002216863A Ceased AU2002216863B8 (en) 2000-12-21 2001-12-21 Streptococcus pyogenes antigens and corresponding DNA fragments

Country Status (12)

Country Link
US (5) US7595057B2 (cg-RX-API-DMAC7.html)
EP (1) EP1343895B1 (cg-RX-API-DMAC7.html)
JP (1) JP4080876B2 (cg-RX-API-DMAC7.html)
AT (1) ATE398677T1 (cg-RX-API-DMAC7.html)
AU (2) AU1686302A (cg-RX-API-DMAC7.html)
BE (1) BE2021C506I2 (cg-RX-API-DMAC7.html)
BR (1) BR0116704A (cg-RX-API-DMAC7.html)
CA (2) CA2432525C (cg-RX-API-DMAC7.html)
DE (1) DE60134494D1 (cg-RX-API-DMAC7.html)
ES (1) ES2307564T3 (cg-RX-API-DMAC7.html)
FR (1) FR21C1005I2 (cg-RX-API-DMAC7.html)
WO (1) WO2002050107A2 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7595057B2 (en) * 2000-12-21 2009-09-29 Id Biomedical Corporation Streptococcus pyogenes antigens and corresponding DNA fragments
GB0130228D0 (en) * 2001-12-18 2002-02-06 Hansa Medica Ab Protein
ES2432013T3 (es) * 2003-08-15 2013-11-29 Id Biomedical Corporation Of Quebec Composiciones farmacéuticas para usar en el tratamiento de la infección por Streptococcus Pyogenes
GB201502305D0 (en) 2015-02-12 2015-04-01 Hansa Medical Ab Protein
GB201502306D0 (en) 2015-02-12 2015-04-01 Hansa Medical Ab Protein
AU2024241785A1 (en) * 2023-03-29 2025-11-13 Cyrus Biotechnology, Inc. Ides variant proteins and methods of using the same

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5854416A (en) * 1991-11-14 1998-12-29 The United States Of America As Represented By The Department Of Health And Human Services Streptococcus pneumoniae 37-KDA surface adhesin a protein and nucleic acids coding therefor
US6287574B1 (en) 1995-03-17 2001-09-11 Biochem Pharma Inc. Proteinase K resistant surface protein of neisseria meningitidis
EP1757697A3 (en) * 1998-02-20 2007-05-30 ID Biomedical Corporation Group B streptococcus antigens
GB9807890D0 (en) * 1998-04-09 1998-06-10 Actinova Ltd Peptides
JP2002531055A (ja) 1998-07-27 2002-09-24 マイクロビアル テクニクス リミティッド 肺炎連鎖球菌のタンパク質及び核酸分子
CA2337102A1 (en) 1998-07-27 2000-02-10 Richard William Falla Le Page Nucleic acids and proteins from group b streptococcus
US7128918B1 (en) * 1998-12-23 2006-10-31 Id Biomedical Corporation Streptococcus antigens
GB9828880D0 (en) * 1998-12-31 1999-02-17 Actinova Ltd Protein
US7074415B2 (en) * 2000-06-20 2006-07-11 Id Biomedical Corporation Streptococcus antigens
CA2413576C (en) * 2000-07-06 2012-11-13 Shire Biochem Inc. Streptococcus pyogenes antigens
AU2002210301A1 (en) * 2000-10-13 2002-04-22 Shire Biochem Inc. Bvh-a2 and bvh-a3 antigens of group b streptococcus
EP2277894A1 (en) * 2000-10-27 2011-01-26 Novartis Vaccines and Diagnostics S.r.l. Nucleic acids and proteins from streptococcus groups A & B
US7595057B2 (en) * 2000-12-21 2009-09-29 Id Biomedical Corporation Streptococcus pyogenes antigens and corresponding DNA fragments
BRPI0207447B1 (pt) * 2001-02-21 2015-09-22 Id Biomedical Corp polipeptídeo recombinante isolado, seu uso e processo de produção, vetor de expressão, célula hospedeira microbiana transgênica, composição farmacêutica, uso da dita composição, métodos de detecção e kit
MXPA03009294A (es) * 2001-04-13 2004-04-20 Wyeth Corp Proteinas de superficie de streptococcus pyogenes.
JP4374245B2 (ja) * 2001-07-06 2009-12-02 アイディー バイオメディカル コーポレイション グループｂ連鎖球菌の抗原及び対応するｄｎａ断片
GB0130228D0 (en) * 2001-12-18 2002-02-06 Hansa Medica Ab Protein
WO2003054007A2 (en) * 2001-12-20 2003-07-03 Shire Biochem Inc. Streptococcus antigens
AU2003246495A1 (en) * 2002-07-15 2004-02-02 Id Biomedical Corporation Polypeptide of streptococcus pyogenes
ES2432013T3 (es) * 2003-08-15 2013-11-29 Id Biomedical Corporation Of Quebec Composiciones farmacéuticas para usar en el tratamiento de la infección por Streptococcus Pyogenes
AU2005294275B2 (en) * 2004-10-08 2012-09-13 Glaxosmithkline Biologicals S.A. Immunogenic and therapeutic compositions for Streptococcus pyogenes
CA2611646C (en) * 2005-06-09 2015-08-11 Hansa Medical Ab Use of the ides proteinase (from s. pyogenes) for treating autoimmune diseases and graft rejection
US8309096B2 (en) * 2007-01-15 2012-11-13 Glaxosmithkline Biologicals S.A. Fusion protein
EP2190984B1 (en) * 2007-09-14 2013-09-04 Genovis Ab Methods and kits for purification and detection of glycosylated IgG
GB201003920D0 (en) * 2010-03-09 2010-04-21 Glaxosmithkline Biolog Sa Method of treatment
GB201115841D0 (en) * 2011-09-13 2011-10-26 Genovis Ab Protein and method
GB201316744D0 (en) * 2013-09-20 2013-11-06 Genovis Ab Method
GB201416849D0 (en) * 2014-09-24 2014-11-05 Genovis Ab Method

Also Published As

Publication number Publication date
AU2002216863B2 (en) 2008-02-28
WO2002050107A2 (en) 2002-06-27
CA2789252A1 (en) 2002-06-27
JP4080876B2 (ja) 2008-04-23
AU2002216863B8 (en) 2008-03-20
CA2789252C (en) 2016-11-15
ES2307564T3 (es) 2008-12-01
DE60134494D1 (de) 2008-07-31
US20100119507A1 (en) 2010-05-13
US20040097706A1 (en) 2004-05-20
US20150017684A1 (en) 2015-01-15
FR21C1005I1 (cg-RX-API-DMAC7.html) 2021-03-26
ES2307564T9 (es) 2021-04-26
US8821895B2 (en) 2014-09-02
FR21C1005I2 (fr) 2022-01-14
EP1343895B1 (en) 2008-06-18
ATE398677T1 (de) 2008-07-15
US7595057B2 (en) 2009-09-29
US20130136760A1 (en) 2013-05-30
CA2432525C (en) 2012-11-27
US20160326221A1 (en) 2016-11-10
BE2021C506I2 (cg-RX-API-DMAC7.html) 2021-05-31
JP2004524014A (ja) 2004-08-12
US9340586B2 (en) 2016-05-17
BR0116704A (pt) 2003-12-23
US8298551B2 (en) 2012-10-30
WO2002050107A3 (en) 2003-04-10
EP1343895A2 (en) 2003-09-17
CA2432525A1 (en) 2002-06-27

Similar Documents

Publication Publication Date Title
BE2021C506I2 (cg-RX-API-DMAC7.html)
AU7227001A (en) Streptococcus pyogenes antigens
MY125202A (en) Vaccine
WO2003054007A3 (en) Streptococcus antigens
WO2004030608A3 (en) Nanoemulsion vaccines
MXPA05002014A (es) Acidos nucleicos inmunoestimuladores.
MY129319A (en) Crystal forms of azithromycin
SG165981A1 (en) Nucleic acids and proteins from streptococcus groups a & b
CY1117746T1 (el) Αντιγονα αιμοφιλου της γριπης και αντιστοιχα θραυσματα dna
IL165988A0 (en) Process for the preparation of fibrinogen
GB0216002D0 (en) Process and composition
AU2001259217A1 (en) Human pellino polypeptides
WO2002066650A3 (en) Streptococcus pyogenes polypeptides and corresponding dna fragments
AU5554301A (en) Isolation and characterization of the csa operon (etec-cs4 pili) and methods of using same
IL156799A0 (en) Peptides having affinity for the gp120 viral protein and use thereof
AU2002327795A1 (en) Methods and compositions for production and purification of recombinant staphylococcal enterotoxin b (rseb)
NZ295877A (en) A vaccine comprising the helicobacter bacterium and its use
DE60234772D1 (de) Gruppe-b streptococcus antigene und entsprechende dna-fragmente
PL346549A1 (en) Peptide fragments of cholera toxin b or enterotoxin b as vaccine adjuvants
WO2003059252A3 (en) Use of a novel cell surface protease from group b streptococcus
TNSN05052A1 (en) Immunostimulatory nucleic acids
AU2002229850A1 (en) Polypeptide inducing hiv-neutralising antibodies
WO2002079475A3 (en) Streptococcus pyogenes antigens and corresponding dna fragments
AU6709500A (en) Trehalose producing cells as vaccines
WO2002088178A3 (en) Antigens of group b streptococcus and corresponding dna fragments